Unitedhealth Group Incorporated Stock Price To Book
| UNHH34 Stock | 49.49 2.02 4.26% |
UnitedHealth Group Incorporated fundamentals help investors to digest information that contributes to UnitedHealth Group's financial success or failures. It also enables traders to predict the movement of UnitedHealth Stock. The fundamental analysis module provides a way to measure UnitedHealth Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to UnitedHealth Group stock.
UnitedHealth |
UnitedHealth Group Incorporated Company Price To Book Analysis
UnitedHealth Group's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current UnitedHealth Group Price To Book | 6.68 X |
Most of UnitedHealth Group's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UnitedHealth Group Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, UnitedHealth Group Incorporated has a Price To Book of 6.6793 times. This is 73.99% lower than that of the Healthcare sector and significantly higher than that of the Healthcare Plans industry. The price to book for all Brazil stocks is 29.77% higher than that of the company.
UnitedHealth Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses UnitedHealth Group's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of UnitedHealth Group could also be used in its relative valuation, which is a method of valuing UnitedHealth Group by comparing valuation metrics of similar companies.UnitedHealth Group is rated below average in price to book category among its peers.
UnitedHealth Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 2.7 T | |||
| Shares Outstanding | 65.4 B | |||
| Price To Book | 6.68 X | |||
| Price To Sales | 8.35 X | |||
| Revenue | 322.13 B | |||
| Gross Profit | 79.62 B | |||
| EBITDA | 31.84 B | |||
| Net Income | 20.12 B | |||
| Total Debt | 54.51 B | |||
| Book Value Per Share | 2.49 X | |||
| Cash Flow From Operations | 26.21 B | |||
| Earnings Per Share | 1.58 X | |||
| Price To Earnings To Growth | 1.64 X | |||
| Number Of Employees | 10 | |||
| Beta | 0.69 | |||
| Market Capitalization | 2.42 T | |||
| Total Asset | 245.71 B | |||
| Z Score | 27.4 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 245.71 B | |||
| Last Dividend Paid | 6.4 |
About UnitedHealth Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UnitedHealth Group Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UnitedHealth Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UnitedHealth Group Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in UnitedHealth Stock
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.